Lung Cancer Considered

We’ve approached a remarkable close to the last day of the IASLC 2022 World Conference on Lung Cancer in Vienna, Austria. Lung Cancer Considered hosts Dr. Stephen Liu and Dr. Narjust Florez interview Dr. Belinda King Kallimanis, Dr. Charles Rudin and Dr. Solange Peters about patient-centric clinical trial consent forms, an update on the Keynote 604 trial, the importance of women’s sexual health an...

Destacados Diarios WCLC 2022 - 8 de Agosto Es el tercer día de la Conferencia Mundial IASLC 2022 sobre Cáncer de Pulmón! La Dra. Narjust Florez recibe a dos investigadores fundamentales: El Dr. Mariano Provencio y La Dra. Enriqueta Felip, para discutir sus estudios mejor calificados.

It’s Day 3 at the IASLC 2022 World Conference on Lung Cancer! Dr. Narjust Florez hosts pivotal researchers Dr. Enriqueta Felip, Dr. Mariano Provencio, and Dr. Rachael Murray to discuss their top-rated studies. IASLC President Dr. Heather Wakelee also joins in to give insight on how the committee selected these high-ranked abstracts for this year’s Presidential Symposium.

In this special edition of Lung Cancer Considered recorded at the IASLC 2022 World Conference on Lung Cancer, hosts Dr. Narjust Florez and Dr. Stephen Liu interview researchers Dr. Chi-Fu Jeffrey Yang, Dr. Jarushka Naidoo and Mr. Koen de Nijs, PhD student, to discuss their recent findings from the significant studies presented today.

Today's podcast originates from the IASLC World Conference on Lung Cancer in Vienna. Hosts Dr. Stephen Liu and Dr. Narjust Florez interview IASLC WCLC 2022 Honorary Chair Dr. Robert Pirker and Chair Dr. Silvia Novello at the meeting. Dr. Pirker and Dr. Novello provide an overview of the meeting and give podcast listeners a glimpse of what to expect at the IASLC WCLC 2022.

On this episode of Lung Cancer Considered, three past IASLC Fellowship Grants winners share their own stories of how these grants helped propel their careers. Hosted by Dr. Narjust Florez, guests include: Dr. Grace Dy is an associate professor of medicine at Department of Medicine at Jacobs School of Medicine & Biomedical Sciences at the University of Buffalo and a medical thoracic oncologist at R...

The IASLC World Conference on Lung Cancer will be held in person this year in Vienna. Lung Cancer Considered Hosts Dr. Narjust Florez and Dr. Stephen Liu preview the meeting highlights and provide advice on how to plan your own experience and what scientific sessions might be the most interesting. This podcast episode is a must listen for all in person attendees and those participating virtually f...

In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion of the unique challenges women in oncology face as they navigate career pathways. She is joined by Dr. Prunella Blinman, a medical oncologist at Concord Repatriation General Hospital in Sydney, Australia and clinical associate professor at the University of Sydney. Also joining the discussion is Dr. Clarissa Math...

In keeping with IASLC's international focus, this episode of Lung Cancer Considered focuses on the state of lung cancer in Germany. This episode is hosted by Dr. Alessandra Curioni, Thoracic Medical Oncologist at the University of Zurich and her guests are two of the most prominent lung cancer experts in Germany -- Dr. Martin Reck, Head of the Department of Thoracic Oncology and the Head of the Cl...

This episode of Lung Cancer Considered examines the state of lung cancer care and research in South Africa. Joining host Dr. Stephen Liu is Dr. Ronwyn van Eeden, a medical oncologist practicing in Rosebank, South Africa. Dr. van Eeden has just started her own oncology unit and is also an honorary consultant in medical oncology at the Chris Hani Baragwanath Academic Hospital.

Dr. Marina Garassino and Dr. Suresh Ramalingam join Lung Cancer Considered host Dr. Narjust Florez to share experiences as international medical graduates. Dr. Garassino is an internationally recognized expert in the treatment of thoracic malignancies from the Medical School of Università degli Studi of Milan, Italy, She recently joined the University of Chicago as the chief of the Thoracic Oncolo...

In this episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss the recently completed ASCO meeting with colleagues Dr. Catherine Shu and Dr. Jack West. Dr. Shu is a board-certified medical oncologist specializing in the treatment of thoracic cancers, especially lung cancer, at Columbia University's Herbert Irving Comprehensive Cancer Center. Dr. West is a medical o...

What are Antibody Drug Conjugates, and do they have a promising future in lung cancer treatment? To discuss this topic, Lung Cancer Considered host Dr. Stephen Liu is joined by Dr. Rebecca Heist, associate director of clinical research at Massachusetts General Hospital Cancer Center in Boston, and Dr. Ben Levy, clinical director of medical oncology at the Johns Hopkins University Sidney Kimmel Com...

India is an extremely diverse and populous country with just under 1.5 billion people. And as with every country in the world, lung cancer represents a major threat to public health. In this episode of Lung Cancer Considered, host Dr. Stephen Liu talks about the state of lung cancer in India with Dr. Navneet Singh, Professor in the Department of Pulmonary Medicine at the Postgraduate Institute of...

Providing smoking cessation without contributing to the stigma faced by those who smoke is a worthwhile goal. To discuss this in greater detail, Lung Cancer Considered host Dr. Narjust Duma welcomes Dr. Jamie Ostroff, Dr. Matthew Steliga, and Jim Pantelas. Dr. Ostroff is the Joseph Gaumont Chair of Cancer Prevention and the Director of the Memorial Sloan Kettering Tobacco Treatment Program and Dr....

Dr. Hilary Robbins, an epidemiologist with the International Agency for Research on Cancer, and Dr. Brendon Stiles, chief of Thoracic Surgery and Surgical Oncology at Montefiore-Einstein Cancer Center in New York, join Lung Cancer Considered host Dr. Stephen Liu to discuss the current status of lung cancer screening research and challenges to implementing it on a national and international scale.

On a special Earth Day episode of Lung Cancer Considered, host Dr. Stephen Liu is joined by two vocal IASLC members who have taken a passionate interest in understanding more about the climate crisis and how it impacts our patients with lung cancer.

In the 100th episode of IASLC's Lung Cancer Considered, host Dr. Narjust Duma interviews new IASLC CEO, Dr. Karen Kelly. Dr. Kelly is recognized internationally for her expertise in lung cancer research and her career has been dedicated to providing enhanced cancer care through innovative and groundbreaking clinical trials. Dr. Kelly’s lung cancer research has involved all aspects of the disease f...

In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recently completed European Lung Cancer Congress. His guests include Dr. Lizza Hendriks, assistant professor at Maastricht University in the Netherlands. Dr. Hendriks is also a pulmonologist specializing in thoracic oncology and the program leader of the Innovative Cancer Diagnostics Therapy group at GROW School of Oncol...

In this episode of Lung Cancer Considered, host Dr. Narjust Duma talks with Dr. Robert C. Doebele, Co-Founder and Chief Scientific Officer, Rain Therapeutics about NTKR gene fusions, including recent and emerging breakthrough therapies.

The IASLC Targeted Therapies Meeting has historically been a very interactive, fast-paced meeting that highlights the latest and most innovative anticancer drugs, initially focused on targeted agents but in recent years, extending to immunotherapy. In this Lung Cancer Considered podcast hosts Dr. Narjust Duma and Dr. Stephen Liu lead a wide-ranging discussion of the meeting with three lung cancer...

Neurotrophic tyrosine receptor kinase fusion, or NTRK, has emerged in the last six years as a rare, but targetable alteration in several cancers. Dr. Herbert Loong, clinical assistant professor in the department of clinical oncology and deputy medical director of the Phase 1 Clinical Trials Center of The Chinese University of Hong Kong, joins Lung Cancer Considered host Dr. Stephen Liu to discuss...

Lung Cancer Considered hosts Dr. Narjust Duma and Dr. Stephen Liu discuss ALK-fusion positive NSCLC with Dr. Jessica Lin, a physician at the Massachusetts General Hospital Cancer Center and an Assistant Professor of Medicine at Harvard Medical School, and Dr. Ben Solomon, a professor and consultant medical oncologist at Peter MacCallum Cancer Center in Melbourne, Australia.

In this episode of Lung Cancer Considered, host Dr. Stephen Liu talks with Dr. Zosia Piotrowska, Assistant Professor of Medicine Harvard Medical School Massachusetts General Hospital in Boston, Mass., about the current and future state of therapies for patients with EGFR mutant lung cancer.

Cell therapy has made strides in hematology and oncology and has recently shown promise in thoracic oncology. In this episode of Lung Cancer Considered host, Dr. Narjust Duma delves into this emerging therapy with guests Dr. Ben Creelan, associate professor of medicine at the University of South Florida, thoracic oncologist at Moffitt Cancer Center and Dr. Prasad Adusumilli, deputy chief and atten...